| Title : [Alzheimer's disease: therapeutic perspectives] - Dubois_2008_Bull.Acad.Natl.Med_192_333 |
| Author(s) : Dubois B , De Souza L , Allali G , Kalafat M , Sarazin M |
| Ref : Bull Acad Natl Med , 192 :333 , 2008 |
|
Abstract :
Current treatments for Alzheimer's disease aim to compensate for biochemical deficits in the brain. They are purely symptomatic and restore the central cholinergic deficit. Acetylcholinesterase inhibitors have modest but significant efficacy on cognitive disorders, activities of daily living, and the global clinical impression. Glutaminergic receptor antagonists are used for more advanced forms. Future treatments may be curative, acting specifically on the amyloid cascade. Secretase inhibitors and immunotherapy are in the pipeline. Trials will begin within a few months and will open up new perspectives. |
| PubMedSearch : Dubois_2008_Bull.Acad.Natl.Med_192_333 |
| PubMedID: 18819687 |
Dubois B, De Souza L, Allali G, Kalafat M, Sarazin M (2008)
[Alzheimer's disease: therapeutic perspectives]
Bull Acad Natl Med
192 :333
Dubois B, De Souza L, Allali G, Kalafat M, Sarazin M (2008)
Bull Acad Natl Med
192 :333